Cure models have historically been utilized to analyse time-to-event data w
ith a cured fraction. We consider the use of frailty models as an alternati
ve approach to modelling such data. An attractive feature of the models is
the allowance for heterogeneity in risk among those individuals experiencin
g the event of interest in addition to the incorporation of a cured compone
nt. Utilizing maximum likelihood techniques, we fit models to data concerni
ng the recurrence of leukaemia among patients receiving autologous transpla
ntation treatment. The analysis suggests that the gamma frailty mixture mod
el and the compound Poisson improve on the fit of the leukaemia data as com
pared to the standard cure model. Copyright (C) 2001 John Wiley & Sons, Ltd
.